Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3095% above fair value
$89.08+0.27 (+0.30%)
Close on Nov 13, 2026Market cap $15.16BP/E 100.1Yield –
Solventum price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Solventum's price to sales ratio was 1.8× on Nov 11, 2026, against 1.8× a year earlier. Over the last 2 years it ranged from 1.3× to 1.9×, with a median of 1.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.8× | +0.2 |
| 2025 | Dec 31, 2025 | 1.6× | +0.2 |
| 2024 | Dec 31, 2024 | 1.4× | – |
See a number that looks wrong?